Personalised Dosimetry in Radioembolisation for HCC: Impact on Clinical Outcome and on Trial Design

Selective internal radiation therapy (SIRT) of hepatocellular carcinoma (HCC) has been used for many years, usually without any specific dosimetry endpoint. Despite good clinical results in early phase studies or in cohort studies, three randomized trials in locally advanced HCC available failed to...

Descripción completa

Detalles Bibliográficos
Autores principales: Garin, Etienne, Palard, Xavier, Rolland, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7353030/
https://www.ncbi.nlm.nih.gov/pubmed/32545572
http://dx.doi.org/10.3390/cancers12061557

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7353030/
https://www.ncbi.nlm.nih.gov/pubmed/32545572
http://dx.doi.org/10.3390/cancers12061557

Ejemplares similares